iShares Biotechnology ETF Stock Price, News & Analysis
Company Description
iShares Biotechnology ETF (NASDAQ: IBB) is a publicly traded company.
IBB stock has gained 34.7% over the past year. Shares last traded at $168.44.
This page provides a comprehensive overview of IBB stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
iShares Biotechnology ETF (IBB) stock last traded at $168.44, down 1.99% from the previous close. Over the past 12 months, the stock has gained 34.7%.
Latest News
iShares Biotechnology ETF has 2 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 0 with negative movement. View all IBB news →
SEC Filings
iShares Biotechnology ETF has filed 1 recent SEC filing, including 1 Form 13F-NT. The most recent filing was submitted on August 12, 2025. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all IBB SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Short interest in iShares Biotechnology ETF (IBB) currently stands at 13.3 million shares, up 5.4% from the previous reporting period, representing 28.5% of the float. This high level of short interest suggests significant bearish sentiment among traders. The 9.1 days to cover indicates moderate liquidity for short covering.
Days to Cover History
Days to cover for iShares Biotechnology ETF (IBB) currently stands at 9.1 days. This moderate days-to-cover ratio suggests reasonable liquidity for short covering, requiring about a week of average trading volume. The days to cover has increased 57.6% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 4.1 to 9.8 days.